Crescent Manor Care Ctrs in Bennington, VT

Crescent Manor Care Ctrs is a medicare and medicaid certified nursing home in Bennington, Vermont. It is located in Bennington county at 312 Crescent Blvd, Bennington, Vermont 05201. You can reach out to the office of Crescent Manor Care Ctrs via phone at (802) 447-1501. This skilled nursing facility has 90 federally certified beds with average occupancy rate of 69.67%. Its legal business name is Cm Healthcare Llc and has the following ownership type - For Profit - Corporation.

Crescent Manor Care Ctrs (Medicare CCN 475033) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1989 (35 years certified) and the last quality survey was conducted in May, 2019.

Name	Crescent Manor Care Ctrs
Location	312 Crescent Blvd, Bennington, Vermont
Certified By	Medicare and Medicaid
No. of Certified Beds	90
Occupancy Rate	69.67%
Medicare ID (CCN)	475033
Legal Business Name	Cm Healthcare Llc
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Crescent Manor Care Ctrs from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1730155409
Organization Name	CSR CORP
Doing Business As	CRESCENT MANOR CARE CTR
Address	312 Crescent Blvd, Bennington, VT 05201
Phone Number	802-447-1501

News Archive

New prostate cancer metastasis prediction method

Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.

Study: Nut consumption associated with decreased risk of some types of cancer, but not type 2 diabetes

Cancer and type 2 diabetes are two of the most significant public health burdens facing the world today, and currently available data suggests their prevalence is expected to continue to increase. Nut consumption has long been hypothesized to have a role in preventing both of these diseases, but until now evidence has been inconsistent.

Lexicon receives FDA Orphan Drug designation for telotristat etiprate to treat carcinoid syndrome

Lexicon Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted its request for Orphan Drug designation for telotristat etiprate (LX1032) for the treatment of carcinoid syndrome.

New PET radiotracer effectively detects early and advanced stages of prostate cancer

In the featured article from the February 2017 issue of the Journal of Nuclear Medicine, researchers document the first-in-human application of a new imaging agent to help find prostate cancer in both early and advanced stages and plan treatment.

Read more Medical News

› Verified 9 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Crescent Manor Care Ctrs are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Crescent Manor Care Ctrs give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

New prostate cancer metastasis prediction method

Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.

Study: Nut consumption associated with decreased risk of some types of cancer, but not type 2 diabetes

Cancer and type 2 diabetes are two of the most significant public health burdens facing the world today, and currently available data suggests their prevalence is expected to continue to increase. Nut consumption has long been hypothesized to have a role in preventing both of these diseases, but until now evidence has been inconsistent.

Lexicon receives FDA Orphan Drug designation for telotristat etiprate to treat carcinoid syndrome

Lexicon Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted its request for Orphan Drug designation for telotristat etiprate (LX1032) for the treatment of carcinoid syndrome.

New PET radiotracer effectively detects early and advanced stages of prostate cancer

In the featured article from the February 2017 issue of the Journal of Nuclear Medicine, researchers document the first-in-human application of a new imaging agent to help find prostate cancer in both early and advanced stages and plan treatment.

Read more Medical News

› Verified 9 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	1
Total Amount of Fines in Dollars	$650
Number of Payment Denials	0
Total Number of Penalties	1

The resident survey data of Crescent Manor Care Ctrs is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	18.1	14.46
Percentage of long-stay residents who lose too much weight	6.48	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	63.19	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	0	1.79
Percentage of long-stay residents with a urinary tract infection	0	2.65
Percentage of long-stay residents who have depressive symptoms	17.75	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	0.42	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	100	93.87
Percentage of long-stay residents who received an antipsychotic medication	45.18	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	96.67	83.88
Percentage of short-stay residents who newly received an antipsychotic medication	0	1.79
Percentage of long-stay residents whose ability to move independently worsened	28.73	17.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication	30.87	19.7
Percentage of high risk long-stay residents with pressure ulcers	1.69	7.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine	100	95.98